A B S T R A C T Serum levels, urinary excretion, and clearances of several proteins of different molecular weights were studied in 18 patients with mono-and myelomonocytic leukemia. Nine patients had normal renal function (group A) and nine had impaired renal function with azotemia (group B). The majority of patients in both groups had increased concentration of immunoglobulins, particularly IgG, IgA, and IgM; IgD level was normal. Serum transferrin and a2-macroglobulin were frequently reduced while the level of ceruloplasmin was often increased, especially in patients with azotemia. The activity of lysozyme in the serum was high in all patients, but was considerably higher in group B.
A B S T R A C T Serum levels, urinary excretion, and clearances of several proteins of different molecular weights were studied in 18 patients with mono-and myelomonocytic leukemia. Nine patients had normal renal function (group A) and nine had impaired renal function with azotemia (group B). The majority of patients in both groups had increased concentration of immunoglobulins, particularly IgG, IgA, and IgM; IgD level was normal. Serum transferrin and a2-macroglobulin were frequently reduced while the level of ceruloplasmin was often increased, especially in patients with azotemia. The activity of lysozyme in the serum was high in all patients, but was considerably higher in group B.
Proteinuria was found in most patients but was more prominent in group B. Almost invariably albumin constituted less than 25% of the total protein excreted. Qualitative analysis of various urinary proteins by immunochemical techniques and clearance studies suggested the presence of glomerular as well as tubular dysfunction. Determination of urinary lysozyme frequently showed no direct correlation between the serum level of the enzyme and its concentration in the urine or its clearance by the kidney. In addition to glomerular filtration, impaired tubular reabsorption may account for the high level of lysozyme in the urine. It is postulated that the very high level of lysozyme in the glomerular filtrate and possibly hypergammaglobulinemia may play a role in the induction of tubular damage. Renal impairment has been correlated with histological changes in the kidneys. From a comparative study of various leukemias, it seems that the combined glomerular-tubular dysfunction is a manifestation unique to mono-and myelomonocytic leukemia.
INTRODUCTION
Hypogammaglobulinemia and susceptibility to infection have been well documented in various leukemias (1) (2) (3) .
However, a few authors have reported an increase rather than a deficiency of serum gammaglobulins in monocytic and myelomonocytic leukemia (4) (5) (6) (7) (8) . Surprisingly, the literature contains little or no information concerning proteinuria in leukemia patients (9) and, with the exception of well documented uric acid nephropathy (10, 11) , the problem of renal injury has been studied from a histologic rather than a functional point of view (12) . The latter has recently assumed importance in view of the demonstration of increased levels of serum and urinary lysozyme (LZM) in mono-and myelomonocytic leukemia (7, 13) . In addition to lysozymuria, other proteins have also been found in the urine of these patients. Some of them have had electrolyte disturbances with hypokalemia and hypomagnesemia (7, 14, 15) . Osserman and Azar have postulated that the abnormally high concentration of LZM in the renal cortex results in injury to the proximal tubular cells, thus contributing to the tubular dysfunction (16) .
The present report concerns our observations on various serum and urinary proteins in 18 patients with mono-and myelomonocytic leukemia. It was found that a majority of the patients had hypergammaglobulinemia.
Renal clearance studies of several proteins of different molecular weights, as well as immunochemical analyses of various urinary proteins suggested that these patients probably had both glomerular and tubular dysfunction. The determination of urinary LZM frequently showed no significant correlation between the serum level of the enzyme and the degree of lysozymuria, or its clearance by the kidney. In addition to glomerular filtration, it is possible that impaired tubular reabsorption and perhaps other mechanisms might be responsible for the high level of LZM in the urine. An attempt has also been made to correlate the histological changes in kidneys with the degree of functional impairment.
METHODS
18 patients with monocytic and myelomonocytic leukemia were divided into two goups (A and B) on the basis of their renal function. Group A consisted of nine patients having normal renal function. In this group, blood urea nitrogen (BUN), serum creatinine, and creatinine clearance were within the normal range. (Normal values were: BUN, 5-25 mg/100 ml; serum creatinine, male 0.9-1.4 mg/100 ml, female 0.8-1.2 mg/100 ml; creatinine clearance, 70-130 ml/min.) Group B consisted of nine patients having renal impairment with azotemia. A group of 20 healthy subjects and 250 patients with various diseases with or without renal failure served as controls. Data pertaining to this part of the study were reported elsewhere (17) .
Samples of serum and urine were examined either immediately or stored at -20°C for varying periods of time. When necessary, samples of urine were concentrated as much as 500-fold, by dialysis in boiled seamless cellulose membranes against 25% polyvinylpyrrolidone or by negative pressure dialysis. Total protein was estimated by the biuret method (18) . Microzone cellulose acetate electrophoresis was performed using 0.075 M barbital buffer, pH 8.6, and the membranes scanned in a Beckman's Analytrol. Immunoelectrophoresis was performed according to the technique of Grabar and Williams (19) with minor modifications. Antisera against whole human serum, IgG, IgA, IgM, transferrin, ceruloplasmin, and Fc and Fab fragments were obtained from Hyland Laboratories, Los Angeles, Calif. Rabbit anti-IgD antiserum (R133A) was kindly provided by the NCI Immunoglobulin Reference Center, Springfield, Va., courtesy of Dr. J. Fahey. This antiserum readily detected a level of 0.3 mg/ml of IgD. Anti-Bence Jones type kappa and lambda antisera and anti-human lysozyme antiserum were prepared in our laboratory by immunizing rabbits with purified Bence Jones proteins from urines of myeloma patients or with human LZM. Purified LZM was generously provided by Dr. E. F. Osserman, New York, and used in conjunction with our own material isolated from the urine of a patient with monocytic leukemia using the technique of Alderton, Ward, and Fevold (20) . The purity of the isolated LZM was verified by electro-and immunoelectrophoresis and by analytical ultracentrifugation. Immunoquantitation of IgG, IgA, IgM, transferrin, ceruloplasmin, and a2-macroglobulin was done using standard immunoplates obtained from Hyland Laboratories, and that of IgD using immunoplates of Kallestad Laboratories Inc., Minneapolis, Minn. The minimal concentration of IgD detectable by these plates was 0.02 mg/ml. Lysozyme quantitation was performed by the lysoplate technique as described by Osserman and Lawlor (7) . Lysozyme activity in the samples tested was compared to that of pure human lysozyme, microgram equivalent per milliliter of buffer. Prepared standards of pure human lysozyme containing 5, 25, 100, 250, and 500 ug/ml were applied to each lysoplate and a semilog curve plotted. Analyses of urinary amino acids were kindly performed by Dr. S. H. Jackson, Hospital for Sick Children, Toronto, using one-dimensional thin-layer chromatography (21) . Clearances of urinary proteins, creatinine, and uric acid were calculated on the basis of 24-hr collections of urine using the formula (U, X U,) / (S. X 1440) = ml/min. The clearances of eight proteins were determined; viz. lysozyme, mol wt 14,000-15,000 (7); transferrin, mol wt 73,000-76,000 (22) ; ceruloplasmin, mol wt 160,000; IgG, mol wt 160,000; IgA and IgD, mol wt 160,000 or higher; a2-macroglobulin, mol wt 840,000; and IgM, mol wt 900,000. The selectivity of protein excretion was examined by plotting the clearance values of IgG and a2-macroglobulin expressed as a percentage of transferrin clearance accepted as 100%, against the respective molecular weights on double-log paper. The slope of the plotted line would be an expression of the selectivity and values exceeding a slope of 670 were accepted as highly selective (23, 24) . The estimation of BUN, uric acid, electrolytes, and creatinine was performed in the same sera and urines in which the proteins were determined. White blood cells were usually counted on the same day that the serum and urines were collected. In three patients, however, there was a lapse of 24-48 hr between these determinations. Autopsy examination was performed in six patients with special attention directed to histological changes in the kidneys. The kidneys of seven additional patients with monocytic or myelomonocytic leukemia (not included in the present study) were also examined.
RESULTS
There were no significant differences in age or sex between groups A and B (Tables I and IV ). The duration of the disease in group A varied from 2 wk to 48 months with a mean of 11 months. In group B, the duration ranged from 3 wk to 24 months, on the average, 5.1 months. Patients without renal failure (group A) often had fewer leukemic cells in the peripheral blood than patients with azotemia (group B). In nine patients, monoblasts were observed in addition to the abnormal monocytes and these cells were included in the total count of monocytes.
Group A (Tables I and II) Serum. By definition, patients included in this group had normal BUN, serum creatinine, and creatinine clearance. Blood urea nitrogen varied between 7 and 23 mg/100 ml and serum creatinine ranged from 0.8 to 1.4 mg/100 ml. Creatinine clearances varied from 71 to 104 ml/min. The serum uric acid was normal in all but one patient in whom a value of 12 mg/100 ml was recorded. The serum potassium was normal in all but two patients (Nos. 4 and 5) in whom values of 3.0 and 3.2 mEq/liter were recorded. In two patients (Nos. 5 and 6) the serum calcium was 7.6 mg/100 ml while the serum phosphorus was normal. No other disorders of electrolytes were found. One of the patients with hypocalcemia (No. 5) also had a low serum albumin of 2.9 g/100 ml.
The total serum protein varied from 4.67 to 9.6 g/100 ml (mean 6.84 +1.33 g/100 ml). In two patients, the level exceeded the normal range and in two others was below normal (normal values, Table III ). The gamma globulin concentration ranged from 0.84 to 3.5 g/100 ml (mean 1.7 ±0.73) with hypergammaglobulinemia in four patients. None had hypogammaglobulinemia. Im- munoquantitation (See Table II) showed IgG concentrations ranging from 550 to 2400 mg/100 ml. Levels exceeding 1600 mg/100 ml were observed in four patients. IgA concentrations varied from 100 to 2360 mg/ 100 ml and exceeded 350 mg/100 ml in three of the same four patients. IgM concentrations ranged from 35 to 322 mg/100 ml and was clearly elevated in only one patient. Among individual cases, one patient had hypergammaglobulinemia involving all three immunoglobulins, and two patients had an increase in both IgG and IgA. In all patients, the level of IgD was either low or normal. The Sia test was positive in one patient who also had a high concentration of IgM. No cryoglobulins or pyroglobulins were found. Serum transferrin was decreased as compared to the normal controls, and varied from 48 to 224 mg/100 ml (mean 121 ±44 mg/100 ml) being 150 mg/100 ml or less in seven patients. Ceruloplasmin varied between 13.4 and 62 mg/ 100 ml (mean 31.8 ±17.7), and was less than 25 mg/100 ml in three patients. a2-Macroglobulin ranged from 148 to 710 mg/100 ml. Urine. The total urinary protein varied from 31 to 1720 mg/24 hr with an average of 524 mg/24 hr, and exceeded 300 mg in five instances. Cellulose acetate electrophoresis of the urinary proteins revealed variable patterns, frequently with low contents of albumin and prominent a2-and f9-proteins. In two patients, lysozyme constituted the major component excreted in the urine, the electrophoretic pattern resembling Fig. 1 a. In seven others, the electrophoretic patterns were similar to those shown in Fig. 1 IgD and IgM were detected in only one urine each. Fc and F'c fragments of IgG were detected in the urines of five patients. This observation bore no relationship to the storage time of the urine since these fragments were observed in three completely fresh urines. In one instance transitory excretion of Bence Jones type kappa protein was noted. Transferrin was excreted in amounts varying from 0 to 33.6 mg/24 hr and comprised up to 37% of the total urinary protein with a mean of 1.34 %. The average clearance of transferrin was approximately twice as high as in healthy persons although a great variability in individual clearances was observed.
Ceruloplasmin varied from 0.78 to 8.65 mg/24 hr, and accounted for 0.09-9.6% of the total urinary protein with a mean of 0.43%. The mean clearance was similar to that in normal controls.
a2-Macroglobulin was excreted in the urines of four patients in amounts varying from 0.87 to 13.54 mg/24 hr. This protein was not found in the urines of nine healthy persons. The C'3 level was tested in five urines and detected in one only in the amount of 8.5 mg/24 hr.
Lysozyme excretion varied greatly from 0.9 mg to 1320 mg/24 hr (mean 142.5). This range included values obtained during remissions. Pretreatment values were always higher with an average excretion of 239 mg/24 hr. (The maximum excretion of LZM in the urines of healthy persons never exceeded 2.9 mg/24 hr.) Lysozyme constituted from 1 to 47.2% of the total urinary protein, with an average of 9.4%. Renal clearances of LZM varied greatly, being in the normal range in 12 instances and increased in 18 others. A correlation coefficient (r) of a linear function was calculated for the serum and urinary LZM levels and also for the serum LZM and Clzm. In the first instance, the correla- All these were included in the calculation of the mean value and standard deviation. * 7 sets of estimations. 14 sets of estimations. tion was significant at the level of P < 0.02 and in the second, at P < 0.025 (Figs. 2 and 3 ). An analysis of the relationship between the level of serum LZM and the amount of urinary LZM revealed three patterns. In 21 instances, both values were proportionally high. Four estimations showed increased serum LZM and normal level of the enzyme in the urine. In these patients, the serum LZM concentration varied from 21.3 to 34 Log/ml and the urinary LZM ranged from 0.48 to 1.97 /eg/ml. In five instances, serum LZM was dysproportionally low as compared to the urinary LZM. The serum values varied from 6.5 to 28.7 ng/ml while the urinary LZM values ranged from 4.1 to 242 .ug/ml. In 16 instances, urinary LZM was high although serum LZM level was increased less than three times as compared to maximum normal value. Here the serum LZM varied from 6.5 to 43 /hg/ml with a mean of 29.2 Ag/ml, whereas urinary LZM ranged from 4.1 to 242 Ag/ml with a mean of 74 /Ag/ml.
Proteins and Rendl Function in Monocytic Leukemias
Investigation of selectivity of protein excretion showed that ratios of CISO/CTf varied from 5.4 to 772 and were below 100 in only five instances. In four patients, the ratios of Ca-2M/CTf varied from 3.5 to 89. Five patients showed no a2-macroglobulin in the urine.
None of the individual cases showed high selectivity pattern.
Uric acid excretion was normal in all but three patients, one with hyperuricemia and two with normal serum uric acid level. Immunoquantitation of IgG (see Table V ) showed values from 930 to 3200 mg/100 ml, the level exceeding 1600 mg/100 ml in eight patients. IgA levels varied from 106 to 1870 mg/100 ml and exceeded 350 mg/100 ml in seven patients. IgD was normal or low. IgM ranged from 36 to 685 mg/100 ml and exceeded 200 mg/100 ml in seven patients. Seven patients showed an increase in all three immunoglobulins, and one an increase in IgG and IgA only. The Sia test was positive in four patients who also had high levels of macroglobulin. One patient had cryoglobulin in the serum and Bence Jones proteinuria.
Transferrin levels varied from 89 to 289 mg/100 ml with values below 150 mg/100 ml in four patients. Three patients suffered from bacterial infection during the study (Nos. 1, 7, and 9), requiring treatment with antibiotics. The gammaglobulins were reduced in one of these and increased in two. Transferrin was 173, 176, and 263 mg/100 ml, respectively.
Ceruloplasmin ranged from 22.4 to 100 mg/100 ml and was less than 25 mg/100 ml in one serum only. ac2-Macroglobulin varied from 130 to 370 mg/100 ml. In four patients, the level was low (200 mg/100 ml or less). Serum LZM varied from 28.2 to 150 Ag/ml with a mean of 85 ±36.8 isg/ml. C'3 was estimated in three cases and varied from 100 to 254 mg/100 ml.
Urine. The total protein excreted in the urine ranged from 0.83 to 6.64 g/24 hr (mean 3.1 ±2.04 g). calcium was also low (7.4 and 7.7 mg/100 ml) with a low serum phosphorus and magnesium in one patient. The latter patient had hypoalbuminemia of 2.8 g/100 ml and suffered from chronic pyelonephritis in addition to leukemia. In two other patients (Nos. 6 and 8) a single estimation also showed hypokalemia. The total serum protein varied from 5.6 to 8.5 g/100 ml (mean 7.14 ±0.84/100 ml). It was in excess of normal in one patient, and below the normal range in two. Gamma globulin ranged from 0.90 to 3.67 g/100 ml (mean 2.26 ±0.84 g/100 ml). The level exceeded the upper normal limit in seven patients. None were subnormal. U-LZM ug/mi FIGURE 2 Group A. Relationship between serum lysozyme (S-LZM) and urinary lysozyme (U-LZM), 30 (1, 3, (25) (26) (27) . In contrast, studies in patients with mono-and myelomonocytic leukemia have revealed significant hypergammaglobulinemia, affecting particularly IgG and IgA (5, 7, 15) .
In our series, serum IgG and IgA were increased in 12 patients and IgM was increased in 8 patients. In general, the increase was greater in patients with renal failure. There was no increase in IgD. Only 2 of 18 patients had acute intercurrent infection, while one had chronic pyelonephritis. Hypergammaglobulinemia was evident in two of the three patients while one had hypogammaglobulinemia. The remaining 15 patients -showed no evidence of increased susceptibility to infections. It would appear, therefore, that the increased levels of gammaglobulins were not attributable to chronic infection. Thus far, no suitable explanation for the hypergammaglobulinemia has been forthcoming. The observation that some patients may have homogeneous M-components in the serum (5-7, 28, 29) while a few may excrete Bence Jones globulin in the urine may be significant, giving rise to speculations concerning the possible relationship of monocytic to plasmacytic dyscrasia (5, 29) . In this regard, it should be noted that there was no correlation between the number of circu- No reports are available concerning the serum levels of transferrin, ceruloplasmin, a2-macroglobulin, or other proteins in monocytic leukemia. The present study revealed low serum transferrin in 11 patients, in the absence of evidence of hemolysis. Ceruloplasmin was either normal or mildly elevated. a2-Macroglobulin was decreased in nine patients. No correlation was found between the low level of transferrin and the low a2-macroglobulin, the former being more frequent in patients with normal renal function and the latter in patients with azotemia.
Finch, Gnabasic, and Rogoway (30) and Jolles, Sternberg, and Mathe (13) were the first to report an increased serum level of lysozyme (muramidase) in monoblastic and myelomonocytic leukemia. Correlations have been shown between the level of lysozyme and the number of circulating monocytes and granulocytes (7, (31) (32) (33) . The marked variability observed in this correlation has been attributed to differences in the rate of production, tissue binding, or renal handling of the enzyme (7) . However, it is also possible that the total body pool of lysozyme-producing cells and the rate of destruction of the enzyme may play a role. In our series, the serum lysozyme was elevated in all patients during the active phase of the disease, being higher in the presence of azotemia. Renal failure (34, 35) would offer an explanation for the more significant elevation of serum LZM in group B, if it were not for the fact that several of these patients also had much more pronounced peripheral monocytosis than those without azotemia. Therefore, the possibility remains that enhanced production of lysozyme may account for some of this difference.
Osserman and Lawlor and others have noted hypokalemia and hyperkaluria in a number of patients with mono-and myelomonocytic leukemia (7, 14, 15, 36) . Excessive excretion rates of potassium, reduced excretion of titratable acid, and glycosuria were also noted in some patients (15) . In our series, seven patients had hypokalemia, three of whom also had a low serum calcium. Two of the latter also had a low magnesium and one had hypophosphatemia. In several of these patients, attempts were made to correct the low level of serum potassium by administration of 40-80 mEq of potas- There are no detailed studies on proteinuria in leukemia, although patients with lymphatic leukemia have been found to excrete more protein in the urine than normal persons, particularly in regard to gamma globulins (9) . In a series of mono-and myelomonocytic leukemia, proteinuria varying from 1.4 to 6.6 g/24 hr has been recorded, of which lysozyme has constituted up to 40%. Other components have included albumin and some alpha, beta, and gamma globulins (7) . While our own control group of healthy subjects aged 21-62 yr showed proteinuria varying from 59 to 187 mg/24 hr with a mean of 103 mg, in most of our patients the total urinary protein consistently exceeded 300 mg/24 hr, being higher in patients with impaired renal function. Albumin generally constituted less than 25% of the total protein. man and Lawlor and other authors have observed increased lysozymuria in patients with monocytic and monomyelocytic leukemia (7, 31, 46 (49) . Any explanation for the renal damage observed therefore must take into account at least two major differences between monocytic leukemia and other types of leukemia, namely the prominent hypergammaglobulinemia and the increase in lysozyme production with subsequent lysozymuria.
It has been reported that hypergammaglobulinemia may contribute to the development of renal tubular acidosis (50) . Hypergammaglobulinemia and also M-components have been observed in patients with adult Fanconi syndrome (43, 51) . None of our patients had tubular acidosis, aminoaciduria, or glycosuria but all these abnormalities have been reported in a few cases of monocytic leukemia (15) . The fact that immunoglobulin levels were frequently much higher in the patients comprising our group B than in those with normal renal function, may be of some importance. Nevertheless, in the absence of renal tubular acidosis, one would question the role of hypergammaglobulinemia as the most important factor in the production of renal tubular injury.
Recent evidence suggests that high concentrations of lysozyme may damage the proximal tubular cells. Normally, lysozyme is reabsorbed in the proximal convoluted tubule and its concentrations in the cortex may be 10-25 times greater than in the medulla (52) . Exogenous lysozyme injected into animals concentrates in the proximal tubular cells in the form of droplets which may be detected by light microscopy (53) or by immunofluorescent techniques (54) . Renal injury in rats treated with tubular poisons results in greater urinary lysozyme excretion than in those treated with antiglomerular antiserum (34) . Osserman has suggested that humans and rats with monocytic leukemia, as well as rats injected with exogenous lysozyme, develop "lysozyme nephropathy" (55) . It has been shown that the increased concentration of the enzyme in the kidney may be associated with cytoplasmic droplet degeneration of the proximal tubular cells and distortion of the mitochondria and nuclei (16, 36) . Similarly, in autopsy material available to us, droplets of homogenous eosinophilic substances have been found in the proximal tubular cells in 4 of 12 cases studied. The higher levels of serum lysozyme in patients comprising our group B may therefore be of considerable significance in contributing to renal tubular injury. It is possible that the low glomerular filtration rate in these patients may lead to the retention of LZM in the serum and subsequently to the higher concentration of the enzyme in the glomerular filtrate. This leads to the inability of the proximal tubular cells to reabsorb all the enzyme filtered. Spillover of LZM into the urine and possible damage to the tubular cells by LZM itself may consequently appear. It seems improbable that occasional intercurrent infections or hyperuricemia, which are usually treated promptly, contribute to the renal damage.
The analyses of the proteins excreted in the urine would appear to suggest the tubular as well as glomerular dysfunction. In many instances, the electrophoretic patterns of the urinary proteins including a low albumin and an excessive excretion of a-, P-, and ev-globulins, resembled those seen in various tubular disorders. On the other hand, the presence of high molecular weight proteins in the urine suggests that glomerular damage also occurred. The pathogenesis of azotemia and renal failure which were found in 50% of the patients with mono-and myelomonocytic leukemia has not yet been elucidated. Recent observations on the glomerular damage in myeloma (56) or on azotemia found in patients with adult Fanconi syndrome (43) , may imply that, in conditions involving mainly tubular cells, glomerular damage may also occur.
From the comparative study of various leukemias, this particular glomerular-tubular dysfunction appears to be a manifestation unique to mono-and myelomonocytic leukemia.
